ClinicalTrials.gg
CompletedNCT03663972ARCUpdated Jun 18, 2020

Age-related Correlates of Treatment for Late-acquired Sounds

An interventional study of articulation therapy and phonologic treatment in Speech Sound Disorder, Phonology Disorder and Phonology Impairment, sponsored by University of Wyoming. Completed at 1 site in United States. Open to participants aged 4 Years to 8 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2020-06-18.

Sponsored by University of Wyoming · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
16
Allocation
Non-randomized
Ages
4 Years to 8 Years
Sex
All
01

Study summary

Late-acquired sounds, such as /r/ are difficult to learn and many children experience persistent errors on these sounds. The purpose of the present study is to determine whether treating these sounds earlier in the child's life may result in better outcomes.

Read the detailed description

Late-acquired sounds, such as /r/ are difficult to learn and many children experience persistent errors on these sounds. However, these sounds are often treated later in a child's life because they are not expected to be fully acquired until quite late--age 7-8 for some sounds. This practice places treatment in a time of the child's development in which they struggle to learn new sounds.The purpose of the present study is to determine whether treating these sounds earlier in the child's life may result in better outcomes, and to examine treatment efficacy and efficiency for two methods of treatment.

02

Conditions studied

  • Speech Sound Disorder
  • Phonology Disorder
  • Phonology Impairment
  • Phonological Disorder
  • Articulation Disorders in Children
  • Developmental Phonological Disorder
  • Speech Disorders
  • Speech Delay
  • Articulation Disorders, Developmental

Keywords

  • treatment
  • efficacy
  • efficiency
  • late-acquired sounds
03

In context

Speech Sound Disorder

46 studies on the registry are indexed under Speech Sound Disorder; 16 are open to participants now.

This study's enrollment of 16 is below the median of 40 across 39 interventional studies indexed under Speech Sound Disorder.

Browse Speech Sound Disorder studies →

Lead sponsor

University of Wyoming is the lead sponsor of 19 studies on the registry; 6 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
4 Years to 8 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Normal Hearing
  • Typical Receptive Language
  • Speech Sound Disorder
  • No motor speech impairment
  • Typical non-verbal intelligence
  • Produces at least one late-acquired sound with \<7% accuracy
  • Monolingual English-speaking
  • Typical in terms of motoric and neurological development

Exclusion criteria

Exclusionary Criteria:

  • Neurological disorder
  • Hearing loss
  • Nonverbal IQ \< 16th percentile
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Non-randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
16 participants (actual)

Study arms

  • Active comparator
    Motoric Arm

    Children will participate in an intervention based on traditional articulation approaches to speech therapy.

    Behavioral: articulation therapy

  • Active comparator
    Phonologic Arm

    Children will receive intervention that targets the conceptual representation of sounds.

    Behavioral: phonologic treatment

Interventions

  • Behavioralarticulation therapy

    children receive instruction in producing new sounds at the isolation, syllable and word level.

  • Behavioralphonologic treatment

    children receive instruction in producing new sounds at the word level

06

What researchers measure

Primary outcomes

  1. Treatment Efficacy: Number of correct productions of treated speech sounds in treatment words

    Accurate Production of treatment sound at baseline and at posttest

    Time frame: baseline until accuracy criterion is met; up to 18 weeks after final baseline session

  2. Treatment Efficiency: Number of sessions required to meet accuracy criteria

    Number of treatment sessions required to meet accuracy criteria (90% accuracy across three consecutive sessions or a maximum of 35 treatment sessions)

    Time frame: baseline until accuracy criterion is met; up to 18 weeks after final baseline session

  3. Session Length: Mean duration of sessions in minutes

    Start and end time of session is recorded on scoresheet, then number of minutes for each session for each participant is found and the mean across all sessions is calculated.

    Time frame: First treatment session until final treatment session. Final treatment session occurs when accuracy of treatment sound is met (90% accuracy across three consecutive sessions or a maximum of 35 treatment sessions)

Secondary outcomes

  1. Accuracy of production of untreated sounds measured on pretest and posttest probes

    Some children may generalize their skills learned through treatment to sounds that were not treated in the trial.

    Time frame: baseline and at posttest up to 18 weeks after final baseline session

07

Study locations

1 site
  • University of Wyoming
    Laramie, Wyoming 82071, United States
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Jun 2018 to primary completion in Apr 2020, 22 months.

Of 23 interventional studies with no phase under Speech Sound Disorder, half reached primary completion within 57 months of starting (the median), counting those still running; a quarter within 16 and three quarters within 57. This study's 22 months is below that.

How these figures are worked out, and which studies are left out of them.

Registered
Aug 31, 2018
First posted
Sep 10, 2018
StartActual
Jun 11, 2018
Primary completionActual
Apr 30, 2020
CompletionActual
Apr 30, 2020
Last update
Jun 18, 2020
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jun 18, 2020, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03663972
Lead sponsor
University of Wyoming
Responsible party
Breanna Irene Krueger (Assistant Professor, University of Wyoming) — Principal investigator
First posted
Sep 10, 2018
Start date
Jun 11, 2018
Primary completion
Apr 30, 2020
Completion
Apr 30, 2020
Last update
Jun 18, 2020

Study contacts

Breanna I. Krueger, PhD
principal investigator · University of Wyoming

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jun 2020. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion